(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM DERIVADO DE TIENOPIRIDONA NO TRATAMENTO DE DOENÇA RENAL POLICÍSTICA AUTOSSÔMICA DOMINANTE (DRPAD)

Em ExigênciaInvention PatentPCT · EP2021058792

Application data

Number

112022019403

Type

Invention Patent

Filing

04/02/2021

Publication

12/06/2022

PCT

EP2021058792

Progress at the INPI

Technical opinion to answer
  1. Filing04/02/21
  2. Publication12/06/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/11/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

POXEL

FR

See this company's full portfolio

Inventors

P. F. (pessoa física)

CH

S. B. (pessoa física)

FR

S. H. (pessoa física)

FR

Technical data

IPC Classification

Priority claims

EP

20167687.1 · 04/02/2020

Abstract

USO DE UM DERIVADO DE TIENOPIRIDONA NO TRATAMENTO DE DOENÇA RENAL POLICÍSTICA AUTOSSÔMICA DOMINANTE (DRPAD).A presente invenção refere-se ao uso de um derivado de tienopiridona, ou uma composição farmacêutica compreendendo o mesmo, no tratamento de doença renal policística autossômica dominante (DRPAD).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

08/11/2026

RPI 2901

Notificação de entrada na fase nacional - PCT

#1.3

12/06/2022

RPI 2709

Alteração de dados cadastrais

#1.1

10/04/2022

RPI 2700

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.